Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Intangibles (2024 - 2025)

Historic Change in Intangibles for BridgeBio Pharma (BBIO) over the last 2 years, with Q3 2025 value amounting to $2.4 million.

  • BridgeBio Pharma's Change in Intangibles rose 5047.02% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 14420.06%. This contributed to the annual value of $8.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Change in Intangibles is $2.4 million, which was up 5047.02% from $4.5 million recorded in Q2 2025.
  • BridgeBio Pharma's 5-year Change in Intangibles high stood at $4.5 million for Q2 2025, and its period low was $797000.0 during Q1 2024.